Data as of Q4 2025 (Dec 31, 2025)

Strata Critical Medical, Inc

(SRTA)

Financial Statements · SEC EDGAR XBRL

Revenue
$197.1M
+34.3%
Net Income
$41.3M
+251.4%
EPS
$0.50
+242.9%
Gross Margin
20.9%
Op. Income
-$22.4M
+0.8%
FCF
-$58.5M
-75.3%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$197.1M
$146.8M
$225.2M
$146.1M
$50.5M
$197.1M
$146.8M
$225.2M
$146.1M
$50.5M
$156.0M
$117.2M
$183.1M
$123.8M
$40.0M
$41.1M
$29.6M
$42.1M
$22.3M
$10.5M
$60.9M
$50.9M
-
-
-
$63.5M
$52.1M
-$33.2M
-$36.6M
-$24.9M
-$22.4M
-$22.5M
-$68.1M
-$53.5M
-$24.1M
$2.3M
$6.4M
$10.6M
$25.5M
-$19.6M
-$20.1M
-$16.2M
-$57.5M
-$28.0M
-$43.7M
$0
$0
-$1.5M
-$772K
-$3.6M
$41.3M
-$27.3M
-$56.1M
-$27.3M
-$40.1M
$0.50
$-0.35
$-0.76
$-0.38
$-0.93
$0.50
$-0.35
$-0.76
$-0.38
$-0.93
82.1M
77.5M
73.5M
71.2M
42.9M